Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer

Journal of Investigative Dermatology

Volumn 109, Issue 6, 1997, Pages 801-805

  Sikkink, Stephen K ^a   Rehman, Ishtiaq ^a   Rees, Jonathan L ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alternative splicing; Loss of heterozygosity; Squamous cell carcinoma; Tumor suppressor gene

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CHROMOSOME 13Q; CHROMOSOME 3P; CHROMOSOME LOSS; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031450868     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12340991     Document Type: Article

References (45)

1. Baker JC, Jacobson MK: Alteration of adenyl dinucleotide metabolism by environmental stress. Proc Natl Acad Sci USA 83:2350-2352, 1986
2. Baxi MD, McLennan AG, Vishwanatha JK: Characterisation of the HeLa cell DNA polymerase alpha-associated Ap4A binding protein by photoaffinity labeling. Biochemistry 33:14601-14607, 1994
3. Birnboim HC, Doly J: A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7:1513, 1979
4. Boukamp P, Petrussevska RT, Breitkreutz D, Horming J, Markam A, Fusenig NE: Normal keratinization in a spontaneously immortalised aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
5. Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM: Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nature Genetics 3:67-72, 1993
6. Chen LC, Matsumura K, Deng G, et al: Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Research 54:3021-3024, 1994
7. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS: Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592-595, 1979
8. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ: Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56:1142-1145, 1996
9. Devilder MC, Francois S, Bosic C, et al: Deletion cartography around the D13S25 locus in B cell chronic lymphocytic leukemia and accurate mapping of the involved tumor suppressor gene. Cancer Res 55:1355-1357, 1995
10. Druck T, Kastury K, Hadaczek P, et al. Loss of heterozygosity at the familial RCC t (3; 8) locus in most clear cell renal carcinomas. Cancer Res 55:5348-5353, 1995
11. Ehlen T, Dubeau L: Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene 5:219-223, 1990
12. Farr SB, Arnosti DN, Chamberlin MJ, Ames BN: An apaH mutation causes AppppA to accumulate and affects motility and catabolite repression in Escherichia coli. Proc Natl Acad Sci USA 86:5010-5014, 1989
13. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In Vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumours. J Nat Cancer Inst 51:1417-1423, 1973
14. Glover TW, Coyle-Morris JF, Li FP, Brown RS, Berger CS, Gemmill RM, Hecht F: Translocation t (3; 8) (p14. 2; q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14 (FRA3B) in lymphocytes. Cancer Genetics Cytogenetics 31:69-73, 1988
15. Gitarra JR, Duan DR, Weng Y, et al: Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. [Review]. Biochimica et Biophysica Acta 1242:201-210, 1996
16. Hibi K, Takahashi T, Yamakawa K, et al. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7:445-449, 1992
17. Iliopoulos O, Kibel A, Gray S, Kaelin Jr WS: Tumour suppression by the human von Hippel-Lindau gene product. Nature Med 1:822-826, 1995
18. Kanno H, Kondo K, Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847, 1994
19. Kastury K, Baffa R, Druck T, et al. Potential gastrointestinal tumour suppressor locus at the 3p14. 2 FRA3B site identified by homozygous deletions in tumour cell lines. Cancer Res 56:978-983, 1996
20. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87 (2)159-170, 1996
21. Knudson AG: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 54:1437-1443, 1985
22. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y: Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer 72:383-385, 1995
23. Latif F, Tory K, Gnarra J, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320, 1993
24. Lundberg C, Skoog L, Cavenee WK, Nordenskjod, M: Loss of heterozygosity in human ductal breast tumours indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci USA 84:2372-2376, 1987
25. Maestro R, Gasparatto D, Vukosavljevie T, Barzan L, Sulfaro S, Boiocchi M: Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 53:5775-5779, 1993
26. Maiestro R, Piccinin S, Doglioni C, et al: Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 56:1146-1150, 1990
27. Negrim M, Monaco C, Vorechovsky I, et al: The FHIT gene at 3p14, 2 is abnormal in breast carcinomas. Cancer Res 56:3173-3179, 1996
28. Ohta M, Inoue H, Cotticelli MG, et al: The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma-associated t (3; 8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597, 1996
29. Panagopoulos I, Pandiss N, Thelm S, et al: The FHIT and PTPRG gees are deleted in benign proliferative breast disease associated with familiar breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res 56471-4875, 1996
30. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D: Frequent loss of heterizygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613-1616, 1995
31. Quinn AG, Sikkink S, Ress JL: Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 54:4756-4759, 1994a
32. Quinn AG, Campbel CC, Healy E, Rees JL: Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin. J Invest 102:300-303, 1994b
33. Rehman I, Quinn AG, Healy E, Rees JL: High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 344:788-789, 1944
34. Rehman I, Takata M, Wu YY, Rees JL: Genetic change in actinic keratoses. Oncogene 12:2483-2490, 1996
35. Reissman, PT, Koga H, Takahashi R, et al: Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. Oncogene 8:1913-1919, 1993
36. Schott DR, Chang JN, Deng G, Kurisu W, Kuo WI, Gray J, Smith HS: A candidate tumor suppressor gene in human breast cancers. Cancer Res 54:1393-1396, 1994
37. Sozzi G, Veronese ML, Negrim M, et al: The FHIT gene at 3p14. 2 is abnormal in lung cancer. Cell 85:17-26, 1996a
38. Sozzi G, Alder H, Tornielli S, et al: Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 56:2472-2474, 1996b
39. Thiagalingam S, Lisitsyn NA, Hamaguchi M, et al: Evolution of the FHIT gene in colorectal cancers. Cancer Res 56:2936-2939, 1996
40. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM: FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93:9770-9975, 1996
41. Wooster R, Neuhausen SL. Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
42. Wu CL, Sloan P, Read AP, Harris R, Thakker N: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. ancer Research 54:6484-6488, 1994
43. Xu H-T, Hu SX, Cagle PT, Moore GE, Benedict WE: Absence of retinoblastoma expression in primary non-small-cell lung carcinoma. Cancer Res 51:2735-2739, 1991
44. Yokota J, Sugimura T: Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. [review]. FASEB J 7:920-925, 1993
45. Zhang X, Xu HJ, Murakami Y, et al: Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 54:4177-4182, 1994